These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 33870703)

  • 21. Meta-Analysis Comparing Single Versus Dual Antiplatelet Therapy Following Transcatheter Aortic Valve Implantation.
    Maes F; Stabile E; Ussia GP; Tamburino C; Pucciarelli A; Masson JB; Marsal JR; Barbanti M; Côté M; Rodés-Cabau J
    Am J Cardiol; 2018 Jul; 122(2):310-315. PubMed ID: 29861051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-Analysis of Studies Comparing Dual- Versus Mono-Antiplatelet Therapy Following Transcatheter Aortic Valve Implantation.
    Al Halabi S; Newman J; Farkouh ME; Fortuin D; Leya F; Sweeney J; Darki A; Lopez J; Steen L; Lewis B; Webb J; Leon MB; Mathew V
    Am J Cardiol; 2018 Jul; 122(1):141-148. PubMed ID: 29779587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
    Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticoagulation With or Without Antiplatelet Therapy Following Transcatheter Aortic Valve Replacement for Patients With Atrial Fibrillation: A Meta-Analysis.
    Yokoyama Y; Briasoulis A; Takagi H; Kuno T
    Cardiovasc Revasc Med; 2021 Mar; 24():42-47. PubMed ID: 32830088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Insight From the OCEAN-TAVI Registry.
    Kobari Y; Inohara T; Tsuruta H; Yashima F; Shimizu H; Fukuda K; Naganuma T; Mizutani K; Yamawaki M; Tada N; Yamanaka F; Shirai S; Tabata M; Ueno H; Takagi K; Watanabe Y; Yamamoto M; Hayashida K
    JACC Cardiovasc Interv; 2023 Jan; 16(1):79-91. PubMed ID: 36599591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single or dual antiplatelet therapy after transcatheter aortic valve replacement: an updated systemic review and meta-analysis.
    Zuo W; Yang M; He Y; Hao C; Chen L; Ma G
    J Thorac Dis; 2019 Mar; 11(3):959-968. PubMed ID: 31019786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual Antiplatelet Therapy vs. Single Antiplatelet Therapy After Transcatheter Aortic Valve Replacement: An Updated Systematic Review and Meta-Analysis.
    Zhang Y; Shen L; Yang W; He B
    Front Cardiovasc Med; 2021; 8():679703. PubMed ID: 34235187
    [No Abstract]   [Full Text] [Related]  

  • 28. Antithrombotic Strategy After Transcatheter Aortic Valve Replacement: A Network Meta-Analysis.
    Mahalwar G; Kumar A; Majmundar M; Adebolu O; Yendamuri R; Lao N; Barve N; Kreutz RP; Reed GW; Puri R; Dani SS; Kalra A
    Curr Probl Cardiol; 2022 Dec; 47(12):101348. PubMed ID: 35944749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges in Aortic Stenosis: Review of Antiplatelet/Anticoagulant Therapy Management with Transcatheter Aortic Valve Replacement (TAVR): TAVR with Recent PCI, TAVR in the Patient with Atrial Fibrillation, and TAVR Thrombosis Management.
    Sherwood MW; Vora AN
    Curr Cardiol Rep; 2018 Oct; 20(12):130. PubMed ID: 30311013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Replacement: A Meta-Analysis.
    Bogyi M; Schernthaner RE; Loewe C; Gager GM; Dizdarevic AM; Kronberger C; Postula M; Legutko J; Velagapudi P; Hengstenberg C; Siller-Matula JM
    JACC Cardiovasc Interv; 2021 Dec; 14(24):2643-2656. PubMed ID: 34949391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of Antiplatelet Therapy After Transcatheter Aortic Valve Implantation.
    Yerasi C; Forrestal BJ; Case BC; Ben-Dor I; Satler LF; Rogers T; Mintz GS; Waksman R
    Am J Cardiol; 2021 Jun; 149():57-63. PubMed ID: 33753035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal antiplatelet and antithrombotic regimen post-transcatheter aortic valve replacement.
    Moey MYY; Udani K; Nifong LW; Carabello BA; Morris DL; Shah NN
    Eur J Clin Invest; 2023 Dec; 53(12):e14071. PubMed ID: 37539630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex Differences in Outcomes After Transcatheter Aortic Valve Replacement: A POPular TAVI Subanalysis.
    van Bergeijk KH; van Ginkel DJ; Brouwer J; Nijenhuis VJ; van der Werf HW; van den Heuvel AFM; Voors AA; Wykrzykowska JJ; Ten Berg JM
    JACC Cardiovasc Interv; 2023 May; 16(9):1095-1102. PubMed ID: 37164609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative efficacy and safety of antithrombotic therapy for transcatheter aortic valve replacement: a systematic review and network meta-analysis.
    Zhu Y; Zou Z; Huang Y; Zhang L; Chen H; Li Y; Liu C; Li X; Xu D; Zeng Q
    Eur J Cardiothorac Surg; 2020 May; 57(5):965-976. PubMed ID: 31883333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variation in post-TAVR antiplatelet therapy utilization and associated outcomes: Insights from the STS/ACC TVT Registry.
    Sherwood MW; Vemulapalli S; Harrison JK; Dai D; Vora AN; Mack MJ; Holmes DR; Rumsfeld JS; Cohen DJ; Thourani VH; Kirtane A; Peterson ED
    Am Heart J; 2018 Oct; 204():9-16. PubMed ID: 30075326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual or Single Antiplatelet Therapy After Transcatheter Aortic Valve Implantation? A Systematic Review and Meta-Analysis.
    Vavuranakis M; Siasos G; Zografos T; Oikonomou E; Vrachatis D; Kalogeras K; Papaioannou T; Kolokathis MA; Moldovan C; Tousoulis D
    Curr Pharm Des; 2016; 22(29):4596-4603. PubMed ID: 27262328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombotic therapy and cardiovascular outcomes after transcatheter aortic valve implantation in patients without indications for chronic oral anticoagulation: a systematic review and network meta-analysis of randomized controlled trials.
    Guedeney P; Roule V; Mesnier J; Chapelle C; Portal JJ; Laporte S; Ollier E; Zeitouni M; Kerneis M; Procopi N; Barthelemy O; Sorrentino S; Mihalovic M; Silvain J; Vicaut E; Montalescot G; Collet JP
    Eur Heart J Cardiovasc Pharmacother; 2023 Apr; 9(3):251-261. PubMed ID: 36640149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspirin Versus Dual Antiplatelet Therapy in Patients Undergoing Trans-Catheter Aortic Valve Implantation, Updated Meta-Analysis.
    Alkhalil M; Edwards R; Puri R; Kalra A; Zaman A; Das R
    Cardiovasc Drugs Ther; 2022 Apr; 36(2):279-283. PubMed ID: 33587229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meta-Analysis of Stroke and Mortality Rates in Patients Undergoing Valve-in-Valve Transcatheter Aortic Valve Replacement.
    Macherey S; Meertens M; Mauri V; Frerker C; Adam M; Baldus S; Schmidt T
    J Am Heart Assoc; 2021 Mar; 10(6):e019512. PubMed ID: 33682426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Outcomes and Bioprosthetic Valve Function After Transcatheter Aortic Valve Implantation Under Dual Antiplatelet Therapy vs. Aspirin Alone.
    Ichibori Y; Mizote I; Maeda K; Onishi T; Ohtani T; Yamaguchi O; Torikai K; Kuratani T; Sawa Y; Nakatani S; Sakata Y
    Circ J; 2017 Feb; 81(3):397-404. PubMed ID: 28123149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.